Empagliflozin Furanoside Impurity

Empagliflozin Furanoside Impurity Or (4R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-5-[(1R)-1,2-didehyroxyethyl]tetrahydrofuran-3,4-diol,Empagliflozin Furanoside is an impurity of Empagliflozin,Empagliflozin is Sodium–glucose cotransporter 2 (SGLT2) inhibitors,which is an oral diabetes medicine that helps control blood sugar levels.

Additional information on Empagliflozin Furanoside Impurity

Catalogue No.

VE008432

CAS No.

N/A

Molecular Formula

C23H27ClO7

Molecular Weight

450.9 g/mol

Parent drug

Empagliflozin

IUPAC Name

(4R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-5-[(1R)-1, 2-didehyroxyethyl]tetrahydrofuran-3, 4-diol

Synonyms

N/A

References

Sci-Hub, Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure, 10.1056/NEJMoa2022190. (2020). Retrieved January 20, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1056/NEJMoa2022190

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

Empagliflozin Furanoside Impurity

Empagliflozin Furanoside Impurity
Catalogue No.

VE008432

CAS No.

N/A

Molecular Formula

C23H27ClO7

Molecular Weight

450.9 g/mol

Parent drug

Empagliflozin

IUPAC Name

(4R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-5-[(1R)-1, 2-didehyroxyethyl]tetrahydrofuran-3, 4-diol

Synonyms

N/A

References

Sci-Hub, Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure, 10.1056/NEJMoa2022190. (2020). Retrieved January 20, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1056/NEJMoa2022190

Status

In-stock

ListName

Empagliflozin Furanoside Impurity

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden